CareRx Corporation (TSX:CRRX)
Canada
· Delayed Price · Currency is CAD 3.640
-0.030 (-0.82%)
At close: Mar 9, 2026
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 370.24 | 366.71 | 370.75 | 381.73 | 262.63 | Upgrade
|
| Revenue Growth (YoY) | 0.96% | -1.09% | -2.88% | 45.35% | 61.92% | Upgrade
|
| Cost of Revenue | 259.28 | 258.65 | 266.05 | 271.79 | 187.35 | Upgrade
|
| Gross Profit | 110.96 | 108.06 | 104.7 | 109.93 | 75.28 | Upgrade
|
| Selling, General & Admin | 99.56 | 101.28 | 97.87 | 102.55 | 70.52 | Upgrade
|
| Operating Expenses | 99.56 | 101.28 | 97.87 | 102.55 | 70.52 | Upgrade
|
| Operating Income | 11.4 | 6.78 | 6.83 | 7.38 | 4.76 | Upgrade
|
| Interest Expense | -6.68 | -8.9 | -13.86 | -14.89 | -14.65 | Upgrade
|
| Interest & Investment Income | - | 0.06 | 1.26 | 0.28 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.29 | -0.13 | 5.24 | -2.24 | Upgrade
|
| EBT Excluding Unusual Items | 4.72 | -2.34 | -5.91 | -1.98 | -12.08 | Upgrade
|
| Merger & Restructuring Charges | -1.29 | -1.49 | -1.45 | -5 | -8.06 | Upgrade
|
| Impairment of Goodwill | - | - | - | -22.52 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -2.71 | - | Upgrade
|
| Asset Writedown | - | -0.76 | -0.71 | -1.81 | - | Upgrade
|
| Other Unusual Items | -0.08 | 0.13 | -1.53 | -1.87 | -3.6 | Upgrade
|
| Pretax Income | 3.35 | -4.47 | -9.6 | -35.9 | -23.74 | Upgrade
|
| Income Tax Expense | -22.77 | 0.03 | -4.19 | -1.54 | -1.01 | Upgrade
|
| Earnings From Continuing Operations | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 | Upgrade
|
| Net Income to Company | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 | Upgrade
|
| Net Income | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 | Upgrade
|
| Net Income to Common | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 | Upgrade
|
| Shares Outstanding (Basic) | 63 | 60 | 57 | 48 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 60 | 57 | 48 | 35 | Upgrade
|
| Shares Change (YoY) | 7.03% | 5.06% | 20.49% | 36.54% | 72.00% | Upgrade
|
| EPS (Basic) | 0.42 | -0.07 | -0.09 | -0.72 | -0.65 | Upgrade
|
| EPS (Diluted) | 0.41 | -0.07 | -0.09 | -0.72 | -0.65 | Upgrade
|
| Free Cash Flow | 25.23 | 32.4 | 22.65 | 12.29 | 1.92 | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.54 | 0.40 | 0.26 | 0.06 | Upgrade
|
| Gross Margin | 29.97% | 29.47% | 28.24% | 28.80% | 28.66% | Upgrade
|
| Operating Margin | 3.08% | 1.85% | 1.84% | 1.93% | 1.81% | Upgrade
|
| Profit Margin | 7.06% | -1.23% | -1.46% | -9.00% | -8.65% | Upgrade
|
| Free Cash Flow Margin | 6.81% | 8.84% | 6.11% | 3.22% | 0.73% | Upgrade
|
| EBITDA | 29.74 | 22.06 | 22.89 | 21.74 | 16.96 | Upgrade
|
| EBITDA Margin | 8.03% | 6.02% | 6.17% | 5.69% | 6.46% | Upgrade
|
| D&A For EBITDA | 18.33 | 15.28 | 16.07 | 14.35 | 12.21 | Upgrade
|
| EBIT | 11.4 | 6.78 | 6.83 | 7.38 | 4.76 | Upgrade
|
| EBIT Margin | 3.08% | 1.85% | 1.84% | 1.93% | 1.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.